Researchers found that the cancer-driving protein MYC helps tumors repair DNA damage and survive treatment. The discovery could lead to new ways to weaken cancers by shutting down one of their key ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Primary central nervous system (CNS) malignancies present unique therapeutic challenges due to their complex biology, immunosuppressive microenvironment, ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

The CCADDAS AI pipeline revolutionizes MRD detection in CLL, reducing analysis time by 90% while maintaining diagnostic ...

The 39th annual Congress, themed Cytometry: The Next Wave, will spotlight emerging technologies shaping the future of the field. Cytek continues to play a central role in that evolution, advancing ...

New software for Pluto Workstation automates cocktailing, staining, and centrifuge-free washing — running the lab’s existing SOP without coding ...

A new research paper was published in Volume 18 of Aging-US on May 15, 2026, titled “Extracellular vesicles released by ...

Glioblastoma represents the most lethal form of brain cancer, characterized by a 5-y survival rate of approximately 4%. Fibroblast activation protein (FAP), expressed within both the tumor ...

T-cell large granular lymphocyte leukaemia (T-LGLL) is a chronic lymphoproliferative disorder often associated with pure red ...